Vanguard Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$123M Buy
2,193,627
+3,214
+0.1% +$145K ﹤0.01% 1398
2026
Q2
$61.3M Buy
2,190,413
+34,649
+2% +$975K ﹤0.01% 1822
2026
Q1
$61.5M Buy
+2,155,764
New +$73.6M ﹤0.01% 1746

Other funds holding ATRC

Vanguard Capital Management's ATRC Position: Q3 2026 in Review

Vanguard Capital Management increased its AtriCure (ATRC) stake by 0.15% in Q3 2026, buying an estimated $145K and bringing the position to 2,193,627 shares worth $123M. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

Vanguard Capital Management first reported a position in ATRC in Q1 2026 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Vanguard Capital Management held 2,193,627 shares of AtriCure worth $123M as of Q3 2026.
  • Vanguard Capital Management bought 3,214 AtriCure shares in Q3 2026, an estimated $145K.
  • AtriCure made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1398 holding.
  • Vanguard Capital Management first reported a position in AtriCure in Q1 2026 and has held it in 3 quarters since.
  • 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.